205 related articles for article (PubMed ID: 11994404)
1. Beta cell expression of IGF-I leads to recovery from type 1 diabetes.
George M; Ayuso E; Casellas A; Costa C; Devedjian JC; Bosch F
J Clin Invest; 2002 May; 109(9):1153-63. PubMed ID: 11994404
[TBL] [Abstract][Full Text] [Related]
2. Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes.
Casellas A; Salavert A; Agudo J; Ayuso E; Jimenez V; Moya M; Muñoz S; Franckhauser S; Bosch F
Diabetes; 2006 Dec; 55(12):3246-55. PubMed ID: 17130467
[TBL] [Abstract][Full Text] [Related]
3. IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice.
Agudo J; Ayuso E; Jimenez V; Salavert A; Casellas A; Tafuro S; Haurigot V; Ruberte J; Segovia JC; Bueren J; Bosch F
Diabetologia; 2008 Oct; 51(10):1862-72. PubMed ID: 18663428
[TBL] [Abstract][Full Text] [Related]
4. Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets.
Hill DJ; Strutt B; Arany E; Zaina S; Coukell S; Graham CF
Endocrinology; 2000 Mar; 141(3):1151-7. PubMed ID: 10698192
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas.
Lu Y; Ponton A; Okamoto H; Takasawa S; Herrera PL; Liu JL
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E50-8. PubMed ID: 16449294
[TBL] [Abstract][Full Text] [Related]
6. TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin.
Jiang H; Zhu H; Chen X; Peng Y; Wang J; Liu F; Shi S; Fu B; Lu Y; Hong Q; Feng Z; Hou K; Sun X; Cai G; Zhang X; Xie Y
Diabetes; 2007 Jan; 56(1):49-56. PubMed ID: 17192464
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
[TBL] [Abstract][Full Text] [Related]
8. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing IFN-gamma in pancreatic beta-cells are resistant to streptozotocin-induced diabetes.
Gu D; Arnush M; Sawyer SP; Sarvetnick N
Am J Physiol; 1995 Dec; 269(6 Pt 1):E1089-94. PubMed ID: 8572201
[TBL] [Abstract][Full Text] [Related]
10. Evidence from transgenic mice that interferon-beta may be involved in the onset of diabetes mellitus.
Pelegrin M; Devedjian JC; Costa C; Visa J; Solanes G; Pujol A; Asins G; Valera A; Bosch F
J Biol Chem; 1998 May; 273(20):12332-40. PubMed ID: 9575186
[TBL] [Abstract][Full Text] [Related]
11. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice.
Rosenberg L; Lipsett M; Yoon JW; Prentki M; Wang R; Jun HS; Pittenger GL; Taylor-Fishwick D; Vinik AI
Ann Surg; 2004 Nov; 240(5):875-84. PubMed ID: 15492571
[TBL] [Abstract][Full Text] [Related]
12. R-spondin1 deficiency enhances β-Cell neogenesis in a murine model of diabetes.
Chahal JK; Wong VS; Chaboissier MC; Brubaker PL
Pancreas; 2014 Jan; 43(1):93-102. PubMed ID: 24263108
[TBL] [Abstract][Full Text] [Related]
13. Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.
Duvillié B; Currie C; Chrones T; Bucchini D; Jami J; Joshi RL; Hill DJ
Endocrinology; 2002 Apr; 143(4):1530-7. PubMed ID: 11897712
[TBL] [Abstract][Full Text] [Related]
14. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.
Harlan DM; Barnett MA; Abe R; Pechhold K; Patterson NB; Gray GS; June CH
Diabetes; 1995 Jul; 44(7):816-23. PubMed ID: 7540575
[TBL] [Abstract][Full Text] [Related]
15. AAV-mediated pancreatic overexpression of
Mallol C; Casana E; Jimenez V; Casellas A; Haurigot V; Jambrina C; Sacristan V; Morró M; Agudo J; Vilà L; Bosch F
Mol Metab; 2017 Jul; 6(7):664-680. PubMed ID: 28702323
[TBL] [Abstract][Full Text] [Related]
16. Detrimental effect of protracted hyperglycaemia on beta-cell neogenesis in a mouse murine model of diabetes.
Guz Y; Torres A; Teitelman G
Diabetologia; 2002 Dec; 45(12):1689-96. PubMed ID: 12488958
[TBL] [Abstract][Full Text] [Related]
17. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
[TBL] [Abstract][Full Text] [Related]
18. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
19. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
20. Effect of schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes.
El-Wakil HS; Aboushousha TS; El Haddad O; Gamil NB; Mansour T; El-Said H
J Egypt Soc Parasitol; 2002 Dec; 32(3):987-1002. PubMed ID: 12512830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
